Bricanyl® L.P.

Bricanyl® L.P. contains Terbutaline Sulfate, a medication used for managing certain respiratory conditions. It is designed for oral use and is manufactured by Astrazeneca S.A.S. in the EU.

Bricanyl® L.P. is generally used to help manage symptoms associated with respiratory conditions. Terbutaline Sulfate, the active ingredient, is often utilized for its bronchodilator properties, which can aid in opening airways and improving breathing. This medication is typically prescribed for conditions that require long-term management of respiratory symptoms.

Common effects of Bricanyl® L.P. may include relief from respiratory symptoms such as wheezing and shortness of breath. Some users might experience mild side effects, which can vary depending on individual responses to the medication. It is important to monitor how your body reacts to Terbutaline Sulfate and consult a healthcare provider if any concerns arise.

When using Bricanyl® L.P., it is advisable to follow the guidance provided by your healthcare provider. This medication should be stored appropriately and used as directed. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions. Pregnant or breastfeeding individuals should consult their healthcare provider before using this medication.

Bricanyl® L.P. may interact with certain medications, including other bronchodilators, beta-blockers, and some antidepressants. It is important to discuss all current medications with your healthcare provider to ensure safe use. Additionally, consuming alcohol while taking this medication may increase the risk of side effects.